Yuki Enoki Selected Research

Yuki Enoki Research Topics

Disease

12	Infections 06/2023 - 01/2014
7	Neoplasms (Cancer) 05/2024 - 05/2019
7	Clostridium Infections 10/2023 - 11/2018
7	Chronic Renal Insufficiency 10/2023 - 01/2016
6	Poisoning 10/2023 - 10/2021
5	Atrophy 05/2024 - 01/2016
4	Muscular Atrophy (Muscle Atrophy) 01/2023 - 01/2016
3	Pneumonia (Pneumonitis) 07/2023 - 01/2021
3	Bacterial Meningitis 08/2022 - 09/2021
3	Meningitis 08/2022 - 09/2021
3	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2019
3	Sarcopenia 12/2021 - 01/2016
2	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 01/2020
2	Acidosis 01/2023 - 01/2022
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2019
2	Rhabdomyolysis 01/2022 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 10/2017
2	Invasive Candidiasis 11/2021 - 11/2020
2	Candidemia 07/2021 - 11/2020
2	Secondary Hyperparathyroidism 12/2017 - 01/2017
2	Human Influenza (Influenza) 01/2015 - 01/2014
2	Virus Diseases (Viral Diseases) 01/2015 - 01/2014
2	Lung Injury 01/2015 - 01/2014
1	Cardiotoxicity 05/2024
1	Critical Illness (Critically Ill) 11/2023
1	Edema (Dropsy) 11/2023
1	Diarrhea 10/2023
1	Ureteral Obstruction 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Endocarditis 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Foreign Bodies (Foreign Body) 01/2023
1	Osteomyelitis 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Lung Diseases (Lung Disease) 11/2022
1	Bacteremia 03/2022

Drug/Important Bio-Agent (IBA)

10	Vancomycin FDA LinkGeneric 11/2023 - 11/2018
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2014
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2015
6	AntidotesIBA 10/2023 - 10/2021
6	IndicanIBA 10/2023 - 01/2016
5	AlbuminsIBA 05/2024 - 12/2021
4	Carbon MonoxideIBA 05/2024 - 01/2020
4	MethemoglobinIBA 10/2023 - 10/2021
4	Metronidazole (Metric)FDA LinkGeneric 07/2023 - 11/2018
4	MyostatinIBA 01/2023 - 01/2016
4	Daptomycin FDA Link 01/2023 - 06/2021
4	Cyanides (Isocyanides)IBA 01/2023 - 10/2021
4	EchinocandinsIBA 07/2021 - 06/2020
3	tedizolidIBA 11/2023 - 01/2022
3	Human Serum Albumin FDA LinkGeneric 10/2023 - 01/2014
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2022
3	AST 120IBA 01/2023 - 10/2017
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2023 - 10/2021
3	Linezolid (Zyvox)FDA Link 11/2022 - 09/2021
3	Uremic ToxinsIBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2022
2	TeicoplaninIBA 10/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 06/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 01/2022
2	FidaxomicinIBA 05/2023 - 11/2022
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	Cytochrome P-450 CYP3AIBA 01/2022 - 12/2017
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2017
2	Liposomes (Liposome)IBA 12/2021 - 10/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021 - 01/2020
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	Cystatin CIBA 06/2021 - 01/2021
2	PolyenesIBA 11/2020 - 11/2020
2	Sulfates (Sulfates, Inorganic)IBA 01/2020 - 02/2015
2	Parathyroid Hormone (Parathormone)IBA 12/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 01/2014
2	Hydroxyl RadicalIBA 01/2015 - 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	CarrageenanIBA 11/2023
1	PowdersIBA 10/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	cefditoren pivoxil (Spectracef)FDA Link 07/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Charcoal (Charbon)IBA 01/2023
1	Sodium NitriteIBA 01/2023
1	phenyl-2-aminoethyl sulfide (PAES)IBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Apelin ReceptorsIBA 01/2023
1	ApelinIBA 01/2023
1	LigandsIBA 01/2023
1	apelin-13 peptideIBA 01/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2022
1	NivolumabIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022

Therapy/Procedure

7	Therapeutics 05/2024 - 11/2018
2	Aftercare (After-Treatment) 10/2023 - 01/2022
2	Nephrectomy 10/2023 - 01/2023
1	Denervation 01/2023
1	Punctures 01/2023
1	Ligation 01/2023